Treace Medical Concepts, Inc.
Price Action
Technical Summary
CONSOLIDATINGTreace Medical Concepts, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 95), indicating clear outperformance against the broad market. Earnings contraction of 12% provides fundamental context to the price action. However, price is extended 45% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.10 | +11.22% | ABOVE |
| 50 SMA | $3.14 | +45.05% | ABOVE |
| 100 SMA | $2.39 | +90.64% | ABOVE |
| 150 SMA | $2.46 | +85.43% | ABOVE |
| 200 SMA | $3.26 | +40.03% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TMCI in an uptrend right now?
TMCI has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is TMCI overbought or oversold?
TMCI's RSI (14) is 58. The stock is in neutral territory, neither overbought nor oversold.
Is TMCI outperforming the market?
TMCI has a Relative Strength (RS) Rating of 95 out of 99. Yes, TMCI is a market leader, outperforming 95% of all stocks over the past 12 months.
Where is TMCI in its 52-week range?
TMCI is trading at $4.56, which is 59% of its 52-week high ($7.78) and 51% above its 52-week low ($1.17).
How volatile is TMCI?
TMCI has a Beta of 1.61 and 52-week volatility of 84%. It's more volatile than the S&P 500 - expect bigger swings.